Search Results
Found 1 results
510(k) Data Aggregation
(133 days)
The Ameditech ImmuTest™ Drug Screen COC is an In Vitro screen test for the qualitative detection of benzoylecgonine (cocaine metabolite) in human urine at cut-off concentration of 300 ng/ml. This test kit is used to obtain a visual, qualitative result and is intended for professional use.
Not Found
This document is the FDA's acceptance of Ameditech, Inc.'s 510(k) premarket notification for their ImmuTest™ Drug Screen COC. It does not contain information about the study or acceptance criteria.
Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets the acceptance criteria from the provided text. The document is an approval letter, not a study report or technical specification.
Ask a specific question about this device
Page 1 of 1